Company
Indianapolis
Every investor coverage indicates participated in a round Ascension Saint Vincent Heart Center raised.
Companies Ascension Saint Vincent Heart Center acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Mary Norine (Minnow) Walsh | Medical Director | Brandon BioCatalyst, Brandon Capital |
Stories naming Ascension Saint Vincent Heart Center. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Cardiac pacing company EBR Systems says its SOLVE-CRT trial hit its safety and efficacy goals early, keeping a 2024 US approval bid on course; the article also recalls its 2021 ASX listing.